Skip to main content
. 2024 Mar 25;14:7030. doi: 10.1038/s41598-024-57870-w

Table 4.

Laboratory Findings and Postoperative Course.

Control group (n = 48) Experimental group (n = 51) P-value
CRP level (mg/dL)
 POD1 27.68 ± 16.89 26.91 ± 24.18 0.857
 POD3 124.90 ± 67.29 105.88 ± 66.00 0.159
 POD5 80.48 ± 50.84 81.32 ± 66.35 0.942
WBC count (× 103/µL)
 POD1 9.95 ± 2.39 10.46 ± 2.96 0.340
 POD3 8.60 ± 2.78 8.41 ± 2.88 0.741
 POD5 6.44 ± 1.47 6.45 ± 1.90 0.987
Neutrophil (%)
 POD1 79.63 ± 6.08 80.94 ± 5.57 0.267
 POD3 73.87 ± 6.43 73.78 ± 7.55 0.951
 POD5 69.09 ± 5.26 68.22 ± 7.52 0.508
 Postoperative opioid injection (n) 2.02 ± 2.20 2.32 ± 2.15 0.449
Complication cases (n) 30 (62.5%) 32 (62.7%) 0.980
 Grade (Clavian–Dindo) 0.994
  I 13 (27.1%) 14 (27.5%)
  II 17 (35.4%) 18 (35.3%)
Hospital stay Day 6.13 ± 1.06 5.84 ± 1.07 0.191

POD postoperative day, CRP C-reactive Protein, WBC white blood cell.